Detalhe da pesquisa
1.
Promoting social capital, self-management and health literacy in older adults through a group-based intervention delivered in low-income urban areas: results of the randomized trial AEQUALIS.
BMC Public Health
; 21(1): 84, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413233
2.
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Lancet Oncol
; 21(8): 1099-1109, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645282
3.
Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma.
Curr Treat Options Oncol
; 19(7): 36, 2018 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808294
4.
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.
Prostate
; 77(1): 33-40, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27527643
5.
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
N Engl J Med
; 371(11): 1028-38, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25184630
6.
Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies.
Prostate
; 76(5): 512-20, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689606
7.
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
Prostate
; 76(13): 1218-26, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338150
8.
The evolving role of enzalutamide on the treatment of prostate cancer.
Future Oncol
; 12(5): 607-16, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26839021
9.
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.
Prostate
; 75(15): 1814-20, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26306637
10.
11.
Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.
Prostate
; 74(13): 1278-85, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053178
12.
Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.
Prostate
; 74(15): 1560-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25176007
13.
New treatments for bladder cancer: when will we make progress?
Curr Treat Options Oncol
; 15(1): 99-114, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415439
14.
Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trial.
Future Oncol
; 10(3): 351-62, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24559444
15.
Progress in systemic therapy for advanced-stage urothelial carcinoma.
Nat Rev Clin Oncol
; 21(1): 8-27, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945764
16.
CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy.
Int J Cancer
; 133(10): 2398-407, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23661576
17.
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer.
Urol Oncol
; 41(1): 27-34, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756410
18.
Biomarkers characterization of circulating tumour cells in breast cancer patients.
Breast Cancer Res
; 14(3): R71, 2012 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22554015
19.
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res
; 28(7): 1353-1362, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031545
20.
Current Therapy for Metastatic Urothelial Carcinoma.
Hematol Oncol Clin North Am
; 35(3): 469-493, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958146